Action

BTK

Alt Name

Approval Jurisdiction

2019 FDA

Approved for clinical use

mantle cell lymphoma

Brutto

CAS

1691249-45-2

Commercial Vendor

Beigene

Compound Image

Zanubrutinib.png

Compound name

Zanubrutinib

InChI

InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1

InChI Key

RNOAOAWBMHREKO-QFIPXVFZSA-N

MW

471.50

PubChem CID

135565884

Reference

Reference 2

SMILES

C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N

Approved Drug List

1